Biofrontera Inc. Files 8-K with Financial Updates
Ticker: BFRIW · Form: 8-K · Filed: Jun 30, 2025 · CIK: 1858685
Sentiment: neutral
Topics: financial-statements, exhibits, regulation-fd
Related Tickers: BFRI
TL;DR
BFRI filed an 8-K on 6/30/25 with financial statements and exhibits.
AI Summary
Biofrontera Inc. filed an 8-K on June 30, 2025, reporting on financial statements and exhibits. The filing pertains to the company's operations as of the same date, with its principal executive offices located in Woburn, Massachusetts.
Why It Matters
This filing provides investors with updated financial information and exhibits, crucial for assessing the company's current financial health and strategic direction.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and exhibits, not indicating any immediate operational or financial distress.
Key Players & Entities
- Biofrontera Inc. (company) — Registrant
- June 30, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 001-40943 (filing_number) — SEC File Number
- 47-3765675 (ein) — IRS Employer Identification No.
- Woburn, Massachusetts (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on financial statements and exhibits as of June 30, 2025, and to provide a Regulation FD Disclosure.
When was this 8-K report filed?
The 8-K report was filed on June 30, 2025.
Where are Biofrontera Inc.'s principal executive offices located?
Biofrontera Inc.'s principal executive offices are located at 120 Presidential Way, Suite 330, Woburn, Massachusetts, 01801.
What is Biofrontera Inc.'s state of incorporation?
Biofrontera Inc. is incorporated in Delaware.
What is the SEC file number for Biofrontera Inc.?
The SEC file number for Biofrontera Inc. is 001-40943.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding Biofrontera Inc. (BFRIW).